Mode
Text Size
Log in / Sign up
N/A N=29 Supportive Care

Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

Infertility, Female · Deferred Childbearing

Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons — 9 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Investigational Oocyte Cryopreservation (Procedure)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
University of Illinois at Chicago
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons
9
PRIMARY
Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons
9
PRIMARY
Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Cancer Patients
1
PRIMARY
Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Cancer Patients
1

Summary

This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility

Eligibility Criteria

Inclusion Criteria

  • Women aged >18 and 10 mIU/ml for patients having egg freezing for a medical indication
  • Serum FSH > 10 mIU/ml for patients having egg freezing for social reasons
  • Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent (Post Traumatic Stress Disorder, severe depression, bipolar disorder, schizophrenia, severe anxiety and inability to cope)
  • Patients with extensive disease whose therapy is deemed palliative by the medical oncologist
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04616417). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search